Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jef Verheyen"'
Publikováno v:
Clinical nuclear medicine
A right atrial mass was discovered with transthoracic cardiac ultrasound in a complaint-free, 81-year-old man at his yearly cardiological checkup. Further investigation of the mass with transesophageal cardiac ultrasound showed a well-defined nodular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6e0ca4a5727e622ca96bf6bc8e83b1f
https://doi.org/10.1097/rlu.0000000000003051
https://doi.org/10.1097/rlu.0000000000003051
Publikováno v:
Acta cardiologica
A 66-year-old patient was transferred because of progressive dyspnoea NYHA III. Symptoms started 6 months earlier following a laparoscopic robot-assisted prostatectomy. At admission the patient was...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da9a4099c2c85bf572058eb4f81564a
https://doi.org/10.1080/00015385.2020.1740414
https://doi.org/10.1080/00015385.2020.1740414
Autor:
Viviane M. Conraads, Johan Denollet, Paul Beckers, Emeline M. Van Craenenbroeck, Jef Verheyen, Catherine De Maeyer
Publikováno v:
Heart : official journal of the British Cardiac Society
To the Editor we read with interest, but also great concern, the paper by West, et al 1 on their multi-centre randomised cardiac rehabilitation study, suggesting negligible results. This study was covered in the Belgian press and already led to quest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9880950760aa351c7d1069c5b0b7b0
https://hdl.handle.net/10067/975480151162165141
https://hdl.handle.net/10067/975480151162165141
Publikováno v:
Acta cardiologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8b63e67372c7f3c6799b650f63533b
https://hdl.handle.net/10067/1002960151162165141
https://hdl.handle.net/10067/1002960151162165141
Autor:
Jef Verheyen, Viviane M. Conraads, Karin Janssen van Doorn, Tom Vermeulen, Christiaan J. Vrints
Publikováno v:
Acta cardiologica
Whereas effective strategies are available to treat acute cellular cardiac rejection, humoral rejection, also called vascular or antibody-mediated rejection, is more difficult to manage. Antibody-mediated (non-cellular) rejections (AMR) are rare and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2429ae73b35fd3adc24326fc5987afda
https://pubmed.ncbi.nlm.nih.gov/21591590
https://pubmed.ncbi.nlm.nih.gov/21591590